Skip Navigation
Skip to contents

PHRP : Osong Public Health and Research Perspectives

OPEN ACCESS
SEARCH
Search

Articles

Page Path
HOME > Osong Public Health Res Perspect > Volume 2(Suppl 1); 2011 > Article
Articles Tuberculosis Research in Taiwan
Ruwen Jou
Osong Public Health and Research Perspectives 2011;2(Suppl 1):S10-S10.
DOI: https://doi.org/10.1016/j.phrp.2011.11.034
Published online: November 30, 2011
  • 1,279 Views
  • 16 Download

Research Fellow and Head, Reference Laboratory of Mycobacteriology, Taiwan Centers for Disease Control, Adjunct Professor, National Yang-Ming University.

Copyright ©2012, Korea Centers for Disease Control and Prevention

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License () which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

dd class="first" id="idm140160886929840">Tuberculosis (TB) is a leading infectious disease in Taiwan; 13,200 new cases, including 164 multidrug-resistant (MDR), were confirmed in the year of 2010.Aprogram of “Halving TB Prevalence in Ten Years” has been implemented by Taiwan Centers for Disease Control since 2006; which formulated 4 major strategies: (1) amend existing national TB control program; (2) reinforce new case detection mechanism; (3) improve numbers of TB andMDR cases to be cured; and (4) strengthen international collaboration. Research focus can be divided in the following areas: (1) understanding the epidemiology of tuberculosis, including enhancement of surveillance system and development of new molecular methods, for evaluating factors influencing the occurrence and transmission of Mycobacterium tuberculosis; (2) revealing the basic biology of host and M. tuberculosis, including genetic analysis of host and different lineages of strains; (3) assessing and developing new TB diagnostics, including development of improved diagnostic tools for early TB and drug-resistant diagnosis and differentiating nontuberculous mycobacteria; (4) improving and defining effective treatment of TB and MDR TB, including evaluation of new lead compounds and candidate antibiotics against M. tuberculosis using laboratory assays, and supporting research on drug-resistant mechanisms; (5) developing laboratory quality-assurance systems, including certification and timely reporting of laboratory services. Progress of research has contributed to shaping TB program in Taiwan, and more efforts are needed for better TB control.

Figure & Data

References

    Citations

    Citations to this article as recorded by  

      • PubReader PubReader
      • Cited
        CITED
        export Copy
        Close
      • XML DownloadXML Download

      PHRP : Osong Public Health and Research Perspectives